Late Breaking Abstract - Azithromycin for acute COPD exacerbations requiring hospitalization – the BACE trial results

Azithromycin during Acute Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization (BACE). A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial

“…Subgroup analyses……………………………………………………………………………………………………………. [13][14][15][16] Overview of adverse events………………………………………………………………………………………………17-19…”

“…Time-to-first event analyses evaluated TF as a novel composite primary endpoint to capture clinically relevant short-term and long-term outcomes of our intervention. Some of the results of the study have been previously reported in the form of an abstract 14. METHODSSTUDY DESIGNAn investigator-initiated, multi-centre, randomized, double-blind, placebo-controlled trial was performed in 6 academic and 14 non-academic hospitals within Belgium, to prove the effectiveness of azithromycin in the acute treatment of COPD exacerbations requiring hospitalization.…”